Multifunctional Nanomaterials for Ferroptotic Cancer Therapy

14Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Patient outcomes from the current clinical cancer therapy remain still far from satisfactory. However, in recent years, several biomedical discoveries and nanotechnological innovations have been made, so there is an impetus to combine these with conventional treatments to improve patient experience and disease prognosis. Ferroptosis, a term first coined in 2012, is an iron-dependent regulated cell death (RCD) based on the production of reactive oxygen species (ROS) and the consequent oxidization of polyunsaturated fatty acids (PUFAs). Many nanomaterials that can induce ferroptosis have been explored for applications in cancer therapy. In this review, we summarize the recent developments in ferroptosis-based nanomaterials for cancer therapy and discuss the future of ferroptosis, nanomedicine, and cancer therapy.

Cite

CITATION STYLE

APA

Shi, Z., Zheng, J., Tang, W., Bai, Y., Zhang, L., Xuan, Z., … Shao, C. (2022, March 24). Multifunctional Nanomaterials for Ferroptotic Cancer Therapy. Frontiers in Chemistry. Frontiers Media S.A. https://doi.org/10.3389/fchem.2022.868630

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free